AzTrials
AzTrials

Spatial NeglectNibsNeglectNCT05466487

Non-Invasive Brain Stimulation as an Innovative Treatment for Chronic Neglect Patients

A study testing Transcranial Alternating Current Stimulation (tACS) and Visual Scanning Training (VST) in people with Spatial Neglect, run by Maastricht University at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Stroke is a leading cause of neurological impairments in language, motor and cognitive functions. Next to traditional stroke treatment, Non-Invasive Brain Stimulation (NIBS) offers the potential to facilitate stroke recovery as a complementary approach. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Spatial Neglect
What is being tested?
Transcranial Alternating Current Stimulation (tACS) and Visual Scanning Training (VST)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
22 participants
Where
1 siteNetherlands
Study dates
21 Oct 2020to 24 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • neurologically objectified stroke;
  • stroke occurred when patient was 18-80 years of age;
  • chronic stroke (>6 months post-stroke onset);
  • sufficient comprehension and communication skills to benefit from training (based on clinical judgement); and
  • a screening containing four neuropsychological tests will be performed to evaluate the current severity of the neglect, since the diagnosis of neglect may have been established months or even years ago in our sample of chronic stroke patients.

Who cannot join

  • currently engaging in cognitive rehabilitation treatment or neglect treatment;
  • physically or mentally unable to participate (based on clinical judgment);
  • hemianopsia (based on clinical judgement);
  • severe communicative disability, as task descriptions need to be understood;
  • local scalp injuries*;
  • eczema on scalp or psoriasis*;
Show all 10Show fewer
  • diagnosed (neuro)psychiatric or neurodegenerative diseases*;
  • current alcohol and/or drug abuse*; and
  • pregnancy*.
  • due to tACS safety considerations.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University

    Maastricht, Limburg, 6200 MD

Other trials in Netherlands

About this study

Official title: Transcranial Alternating Stimulation in Rehabilitation: a Randomized Controlled Trial in Chronic Stroke Patients With Visuospatial Neglect

Background Stroke is a leading cause of neurological impairments in language, motor and cognitive functions. Next to traditional stroke treatment, Non-Invasive Brain Stimulation (NIBS) offers the potential to facilitate stroke recovery as a complementary approach. Here, we aim at exploiting the principles of NIBS, specifically transcranial Alternating Current Stimulation (tACS), to promote functional recovery of people with neglect symptoms following stroke.

Objective To determine whether neglect training complemented with tACS treatment in chronic stroke patients suffering from neglect improves neglect-related symptoms compared to neglect training with sham stimulation.

Read more

Study design Double-blind randomized placebo-controlled intervention study. After enrollment and completion of baseline measurements, participants are randomly assigned to either the active tACS group or sham (control) group.

Intervention We will combine an evidence based visual scanning training (VST) with 40 minutes of (active or sham) tACS at alpha frequency. The intervention is administered three times a week for a duration of six weeks.

Outcomes of the study Performance on standard, conventional neuropsychological tests, as well as on ADL observation scales.

Conditions
Spatial Neglect
Being tested
Transcranial Alternating Current Stimulation (tACS), Visual Scanning Training (VST)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial Alternating Current Stimulation (tACS)Device

    Stimulation frequency and peak-to-peak intensity will be set to 10Hz and 1.5 milliampere (mA), phase offset will be set to 0 and 100 cycles will be used for ramping up. At the start of the neglect training session, the tACS will be started. When the neglect training session is finished, after maximally 40 minutes, the tACS will be switched off.

  • Visual Scanning Training (VST)Behavioural

    The most common treatment for neglect is VST, which is an intensive compensation training (see Dutch guidelines for rehabilitation of neglect: Ten Brink, Van Kessel, \& Nijboer, 2017). The aim of this training is to improve visual scanning behavior, that is, to encourage neglect patients to actively and consciously pay attention to stimuli on the contralesional side.

Study groups in NCT05466487
Study groupRoleWhat they receive
Active tACSExperimentalNot described
Receives: Device: Transcranial Alternating Current Stimulation (tACS); Behavioral: Visual Scanning Training (VST)
Sham tACSSham comparatorNot described
Receives: Device: Transcranial Alternating Current Stimulation (tACS); Behavioral: Visual Scanning Training (VST)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Star Cancellation Task

    Quality of search score

    Measured: Testing will take place before the training (T0; baseline), after the first (T1), ninth (T2), and eighteenth (T3) training session, as well as one week (T4) and three months (T5) after termination of the training.

Secondary outcomes (6)
  1. Computerized Visual Detection Task

    Sum of weighted hits

    Measured: Testing will take place before the training (T0; baseline), after the first (T1), ninth (T2), and eighteenth (T3) training session, as well as one week (T4) and three months (T5) after termination of the training.

  2. McIntosh Line Bisection Task-digitized

    Endpoint weightings bias

    Measured: Testing will take place before the training (T0; baseline), after the first (T1), ninth (T2), and eighteenth (T3) training session, as well as one week (T4) and three months (T5) after termination of the training.

  3. Schenkenberg Line Bisection Task

    Relative deviation score

    Measured: Testing will take place before the training (T0; baseline), after the first (T1), ninth (T2), and eighteenth (T3) training session, as well as one week (T4) and three months (T5) after termination of the training.

  4. Baking Tray Task

    Average x-coordinate

    Measured: Testing will take place before the training (T0; baseline), after the ninth (T2) training session, as well as one week (T4) and three months (T5) after termination of the training.

  5. Catherine Bergego Scale

    Total score. The CBS is a 10-item observation scale, and results in a total score of 0 (no neglect) to 30 (severe neglect).

    Measured: Testing will take place before the training (T0; baseline), after the ninth (T2) training session, as well as one week (T4) and three months (T5) after termination of the training.

  6. Subjective Neglect Questionnaire

    Total score. The SNQ is a 19-item questionnaire, and results in a total score of 19 (no reported problems) to 95 (many/frequently reported problems).

    Measured: Testing will take place before the training (T0; baseline), after the ninth (T2) training session, as well as one week (T4) and three months (T5) after termination of the training.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2022
  2. Study start21 Oct 2020
  3. Primary completion24 Mar 2023
  4. Study completion24 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05466487
Sponsor's protocol ID
NL70256.068.19
Acronym
NibsNeglect
Status last verified
Oct 2023
First submitted
18 Jul 2022
Last updated
26 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Middag-van Spanje M, Nijboer TCW, Schepers J, van Heugten C, Sack AT, Schuhmann T. Alpha transcranial alternating current stimulation as add-on to neglect training: a randomized trial. Brain Commun. 2024 Aug 30;6(5):fcae287. doi: 10.1093/braincomms/fcae287. eCollection 2024.

    PubMed 39301290
  • Middag-van Spanje M, Schuhmann T, Nijboer T, van der Werf O, Sack AT, van Heugten C. Study protocol of transcranial electrical stimulation at alpha frequency applied during rehabilitation: A randomized controlled trial in chronic stroke patients with visuospatial neglect. BMC Neurol. 2022 Nov 2;22(1):402. doi: 10.1186/s12883-022-02932-7.

    PubMed 36324088

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial Alternating Current Stimulation (tACS) and Visual Scanning Training (VST) in people with Spatial Neglect, run by Maastricht University at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Star Cancellation Task (time frame: Testing will take place before the training (T0; baseline), after the first (T1), ninth (T2), and eighteenth (T3) training session, as well as one week (T4) and three months (T5) after termination of the training.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05466487, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in